[Poly-immunotherapy anti-cancer in man].
D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004136:Dinitrobenzenes / Q000627:therapeutic use; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy; D009369:Neoplasms / Q000188:drug therapy / Q000628:therapy*
D001500:BCG Vaccine; D004136:Dinitrobenzenes
Poli-imunoterapia anti-câncer no homem.